Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
2002 1
2003 1
2004 1
2005 1
2009 4
2010 5
2012 4
2013 4
2014 2
2015 4
2016 9
2017 9
2018 11
2019 7
2020 30
2021 33
2022 35
2023 24
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

176 results

Results by year

Filters applied: . Clear all
Page 1
Intravenous fosfomycin for treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii: a multicenter clinical experience.
Russo A, Gullì SP, D'Avino A, Borrazzo C, Carannante N, Dezza FC, Covino S, Polistina G, Fiorentino G, Trecarichi EM, Mastroianni CM, Torti C, Oliva A. Russo A, et al. Among authors: mastroianni cm. Int J Antimicrob Agents. 2024 Apr 30:107190. doi: 10.1016/j.ijantimicag.2024.107190. Online ahead of print. Int J Antimicrob Agents. 2024. PMID: 38697579
The Long-Term Immunogenicity of mRNABNT162b Third Vaccine Dose in Solid Organ Transplant Recipients.
Zingaropoli MA, Guardiani M, Dominelli F, Tortellini E, Garofalo M, Cogliati Dezza F, Centofanti A, Carillo C, Napoli A, Venuta F, Mastroianni CM, Pretagostini R, Lichtner M, Ciardi MR, Russo G. Zingaropoli MA, et al. Among authors: mastroianni cm. Vaccines (Basel). 2024 Feb 22;12(3):224. doi: 10.3390/vaccines12030224. Vaccines (Basel). 2024. PMID: 38543858 Free PMC article.
COVID-19 vaccination in cancer patients: Immune responses one year after the third dose.
Campagna R, Dominelli F, Zingaropoli MA, Ciurluini F, Grilli G, Amoroso A, De Domenico A, Amatore D, Lia MS, Cortesi E, Picone V, Mastroianni CM, Ciardi MR, De Santis R, Lista F, Antonelli G, Turriziani O. Campagna R, et al. Among authors: mastroianni cm. Vaccine. 2024 Apr 11;42(10):2687-2694. doi: 10.1016/j.vaccine.2024.03.017. Epub 2024 Mar 17. Vaccine. 2024. PMID: 38499458 Free article.
TB specific intracellular cytokines production in Synovial liquid for diagnosis of tuberculous arthritis.
Vita S, Mascia C, Kertusha B, Marocco R, Sauzullo I, Mengoni F, Pozzetto I, Scalzi A, Nijhawan P, Savinelli S, Fondaco L, Carraro A, Del Borgo C, Mastroianni CM, Lichtner M. Vita S, et al. Among authors: mastroianni cm. J Infect Dev Ctries. 2023 Dec 31;17(12):1829-1833. doi: 10.3855/jidc.12618. J Infect Dev Ctries. 2023. PMID: 38252716 Free article.
Association of piperacillin/tazobactam MIC and mortality in a cohort of ceftriaxone-resistant Escherichia coli bloodstream infections treated with piperacillin/tazobactam and carbapenems: a multicentric propensity score-weighted observational cohort study.
Rando E, Salvati F, Sangiorgi F, Catania F, Leone E, Oliva A, Di Gennaro F, Fiori B, Cancelli F, Figliomeni S, Bobbio F, Sacco F, Bavaro DF, Diella L, Belati A, Saracino A, Mastroianni CM, Fantoni M, Murri R. Rando E, et al. Among authors: mastroianni cm. J Antimicrob Chemother. 2024 Feb 1;79(2):453-461. doi: 10.1093/jac/dkad404. J Antimicrob Chemother. 2024. PMID: 38169441 Free PMC article.
A 12-month follow-up of the immune response to SARS-CoV-2 primary vaccination: evidence from a real-world study.
Fedele G, Schiavoni I, Trentini F, Leone P, Olivetta E, Fallucca A, Fiore S, Di Martino A, Abrignani S, Baldo V, Baldovin T, Bandera A, Clerici P, De Paschale M, Diaco F, Domnich A, Fortunato F, Giberti I, Gori A, Grifantini R, Lazzarotto T, Lodi V, Mastroianni CM, Prato R, Restivo V, Vitale F, Brusaferro S, Merler S, Palamara AT, Stefanelli P; Study Group for the Immunological Monitoring post Covid19 vaccination. Fedele G, et al. Among authors: mastroianni cm. Front Immunol. 2023 Nov 20;14:1272119. doi: 10.3389/fimmu.2023.1272119. eCollection 2023. Front Immunol. 2023. PMID: 38077369 Free PMC article.
Steroid use in measles: A retrospective cohort study during the 2017 outbreak in tertiary referral center, Rome and Latina, Italy.
Caraffa E, Mascia C, Ciardi MR, Lichtner M, Ajassa C, Del Borgo C, Tieghi T, Vita S, Savinelli S, Iannetta M, Russo G, Mastroianni CM, Vullo V. Caraffa E, et al. Among authors: mastroianni cm. J Infect Chemother. 2024 Mar;30(3):201-207. doi: 10.1016/j.jiac.2023.10.001. Epub 2023 Oct 10. J Infect Chemother. 2024. PMID: 37820949
Efficacy and Safety of Reparixin in Patients with Severe COVID-19 Pneumonia: A Phase 3, Randomized, Double-Blind Placebo-Controlled Study.
Piemonti L, Landoni G, Voza A, Puoti M, Gentile I, Coppola N, Nava S, Mattei A, Marinangeli F, Marchetti G, Bonfanti P, Mastroianni CM, Bassetti M, Crisafulli E, Grossi PA, Zangrillo A, Desai A, Merli M, Foggia M, Carpano M, Schiavoni L, D'Arminio Monforte A, Bisi L, Russo G, Busti F, Rovelli C, Perrotta E, Goisis G, Gavioli EM, Toya S, De Pizzol M, Mantelli F, Allegretti M, Minnella EM. Piemonti L, et al. Among authors: mastroianni cm. Infect Dis Ther. 2023 Oct;12(10):2437-2456. doi: 10.1007/s40121-023-00871-5. Epub 2023 Oct 5. Infect Dis Ther. 2023. PMID: 37798468 Free PMC article.
176 results